Difference between revisions of "Part:BBa K4165182"
Line 12: | Line 12: | ||
This peptide was proved to completely eliminate neurotoxicity of plaques when tested in vivo, this is due to the hydrophobic interactions between peptide and Aβ oligomers, followed by the formation of non-toxic oligomers. | This peptide was proved to completely eliminate neurotoxicity of plaques when tested in vivo, this is due to the hydrophobic interactions between peptide and Aβ oligomers, followed by the formation of non-toxic oligomers. | ||
− | <span class='h3bb'>Sequence and Features</span> | + | ===<span class='h3bb'>Sequence and Features</span>=== |
<partinfo>BBa_K4165182 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165182 SequenceAndFeatures</partinfo> | ||
Latest revision as of 17:43, 10 October 2022
Amyloid Beta Peptide 2 (Aβ 31-42)
This part encodes a part of the Amyloid 𝛽 fragment (31-42) which has the ability to bind to A𝛽 plaques inside the brain.
Usage and Biology
Segments of amyloid beta fibrils are widely used as a recognition sequence for amyloid beta plaques inside the brain, this is due to the homotypic interactions in the C-terminus of fibrils.
This peptide was proved to completely eliminate neurotoxicity of plaques when tested in vivo, this is due to the hydrophobic interactions between peptide and Aβ oligomers, followed by the formation of non-toxic oligomers.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab Characterization
Modeling
For the prediction of 3D structure, the peptide was modeled through three peptide modeling software (Apptest, Alphafold2, and Pepfold3) followed by ranking them according to our pipeline parameters. Various models for this peptide ranked 6 out of 6, with the top-ranked model being (Apptest model 77).
Figure 1.: Prediction of 3D structure for Aβ(31–42) peptide.
References
Xiong, N., Zhao, Y., Dong, X., Zheng, J., & Sun, Y. (2017). Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β‐Protein Aggregation and Cytotoxicity. Small, 13(13), 1601666. doi: 10.1002/smll.201601666